3D Cellular Models: Revitalizing Phenotypic Screening (1)
Owner/Developer: Cambridge Healthtech Institute
|Country:||United States of America|
Inadequate representation of the human tissue environment during a preclinical screen can result in inaccurate predictions of compound effects. Thus, pharmaceutical investigators are searching for preclinical models that closely resemble original tissue for predicting clinical outcome. Three-dimensional cell culture recapitulates normal and pathological tissue architectures that provide physiologically relevant models to study normal development and disease. However, challenges remain for high-throughput screening as researchers must procure large numbers of identical 3D cell cultures, develop assays and obtain fast, automated readouts from these more complex assays. Join cell biologists, tissue engineers, assay developers, screening managers and drug developers at Cambridge Healthtech Institute’s second annual 3D Cellular Models: Revitalizing Phenotypic Screening conference as they discuss strategies that accelerate the identification of novel therapeutic leads.
|Channel:||Face-to-face - Website|
|Audience:||Researchers - Scientists - Industry|
|User access:||Fee-based access|
|Updating frequency:||Annual meeting|
|Purpose:||Method development - Education and training - Documentation and information|
|Technology/Tools:||3D printing - Alternative test methods (in vitro) - Stem cells - Tissue engineering|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.